“U.S. Army, Emisphere to Study Oral Anthrax Vaccine”

Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

A cooperative research and development agreement established between the U.S. Army’s Medical Research Institute of Infectious Diseases and New York-based Emisphere Technologies will test Emisphere’s oral vaccine delivery technology as a possible method of administering the anthrax vaccine. The technology involves using eligenT delivery agents to transport proteins across membranes where they do not naturally flow, such as the intestine.

Return to Vaccination News Home Page

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.